Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 1
2011 3
2012 4
2013 3
2015 1
2016 2
2017 2
2018 4
2019 5
2020 5
2021 2
2022 7
2023 4
2024 4
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Immune triggers preceding neuralgic amyotrophy.
Sparasci D, Schilg-Hafer L, Schreiner B, Scheidegger O, Peyer AK, Lascano AM, Vicino A, Décard BF, Tsouni P, Humm AM, Pianezzi E, Zezza G, Hundsberger T, Dietmann A, Jung HH, Kuntzer T, Wilder-Smith E, Martinetti-Lucchini G, Petrini O, Fontana S, Gowland P, Niederhauser C, Gobbi C, Ripellino P. Sparasci D, et al. Among authors: scheidegger o. Eur J Neurol. 2024 Dec;31(12):e16462. doi: 10.1111/ene.16462. Epub 2024 Oct 4. Eur J Neurol. 2024. PMID: 39364568 Free PMC article.
[Myositides: What is the current situation?].
Rösler KM, Scheidegger O. Rösler KM, et al. Among authors: scheidegger o. Z Rheumatol. 2015 Aug;74(6):496-506. doi: 10.1007/s00393-014-1547-0. Z Rheumatol. 2015. PMID: 26184954 Free article. Review. German.
Large-scale profiling of antibody reactivity to glycolipids in patients with Guillain-Barré syndrome.
Thomma RCM, Halstead SK, de Koning LC, Wiegers EEJA, Gourlay DS, Tio-Gillen AP, van Rijs W, Andersen H, Antonini G, Arends S, Attarian S, Barroso FA, Bateman KJ, Benedetti L, Van den Bergh P, Bürmann J, Busby M, Casasnovas C, Dardiotis E, Davidson A, Feasby TE, Fehmi J, Galassi G, Garcia-Sobrino T, Granit V, Gutiérrez-Gutiérrez G, Hadden RDM, Harbo T, Hartung HP, Hasan I, Holt JKL, Islam Z, Karafiath S, Katzberg HD, Kolb N, Kusunoki S, Kuwabara S, Kuwahara M, Lehmann HC, Leonhard SE, Martín-Aguilar L, Monges S, Nobile-Orazio E, Pardo J, Pereon Y, Querol L, Reisin RC, Rinaldi S, Ripellino P, Roberts RC, Scheidegger O, Shahrizaila N, Sheikh KA, Silvestri NJ, Sindrup SH, Stein B, Tan CY, Tankisi H, Visser LH, Waheed W, Huizinga R, Jacobs BC, Willison HJ; IGOS consortium. Thomma RCM, et al. Among authors: scheidegger o. Brain. 2025 Mar 17:awaf102. doi: 10.1093/brain/awaf102. Online ahead of print. Brain. 2025. PMID: 40096525 Free article.
Feasibility of transesophageal phrenic nerve stimulation.
Kaufmann EM, Krause S, Geisshuesler L, Scheidegger O, Haeberlin A, Niederhauser T. Kaufmann EM, et al. Among authors: scheidegger o. Biomed Eng Online. 2023 Jan 30;22(1):5. doi: 10.1186/s12938-023-01071-5. Biomed Eng Online. 2023. PMID: 36717872 Free PMC article.
Real-world data on the effect of long-term treatment with nusinersen over > 4 years in a cohort of Swiss patients with spinal muscular atrophy.
Tscherter A, Steiner L, Broser PJ, Enzmann C, Galiart E, Henzi BC, Jacquier D, Mathis AM, Neuwirth C, Ramelli GP, Ripellino P, Scheidegger O, Schreiner B, Schwarz EI, Stettner GM, Klein A; Swiss-Reg-NMD Group. Tscherter A, et al. Among authors: scheidegger o. Clin Neurol Neurosurg. 2025 Aug;255:108983. doi: 10.1016/j.clineuro.2025.108983. Epub 2025 May 26. Clin Neurol Neurosurg. 2025. PMID: 40451126 Free article.
[Neurological Evaluation of Neuropathic Pain].
Blanquet M, Scheidegger O. Blanquet M, et al. Among authors: scheidegger o. Ther Umsch. 2020 Aug;77(6):246-251. doi: 10.1024/0040-5930/a001186. Ther Umsch. 2020. PMID: 32930082 German.
Exploration of New Contrasts, Targets, and MR Imaging and Spectroscopy Techniques for Neuromuscular Disease - A Workshop Report of Working Group 3 of the Biomedicine and Molecular Biosciences COST Action BM1304 MYO-MRI.
Strijkers GJ, Araujo ECA, Azzabou N, Bendahan D, Blamire A, Burakiewicz J, Carlier PG, Damon B, Deligianni X, Froeling M, Heerschap A, Hollingsworth KG, Hooijmans MT, Karampinos DC, Loudos G, Madelin G, Marty B, Nagel AM, Nederveen AJ, Nelissen JL, Santini F, Scheidegger O, Schick F, Sinclair C, Sinkus R, de Sousa PL, Straub V, Walter G, Kan HE. Strijkers GJ, et al. Among authors: scheidegger o. J Neuromuscul Dis. 2019;6(1):1-30. doi: 10.3233/JND-180333. J Neuromuscul Dis. 2019. PMID: 30714967 Free PMC article.
49 results